Press release
Asia-Pacific Biopsy Devices Market Projected to Grow at 8.9% CAGR, Reaching USD 5.4 Billion by 2034
Asia-Pacific Biopsy Devices Market
Biopsy procedures are central to modern medicine, especially in the detection and management of cancer. As the gold standard for diagnosing malignancies, biopsies allow for tissue sampling and pathological analysis to confirm disease presence and determine treatment strategies. In Asia-Pacific, where cancer cases are rapidly increasing due to demographic shifts, lifestyle changes, and environmental factors, the demand for biopsy devices is surging.
The Asia-Pacific Biopsy Devices Market has emerged as a key segment of the region's healthcare ecosystem. Rising healthcare investments, expanding hospital infrastructure, government-led screening initiatives, and technological innovation are driving adoption. As patients and physicians increasingly prefer minimally invasive procedures with high diagnostic accuracy, the market is positioned for strong growth through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72316
Market Overview
According to Exactitude Consultancy, the Asia-Pacific Biopsy Devices Market was valued at USD 2.3 billion in 2024 and is projected to reach USD 5.4 billion by 2034, growing at a CAGR of 8.9% during the forecast period.
Key Highlights
• Increasing cancer prevalence in China, India, and Southeast Asia is the primary demand driver.
• Minimally invasive biopsy techniques are gaining preference over surgical methods.
• Technological advances in imaging-guided and robotic-assisted biopsies are enhancing diagnostic precision.
• Government-sponsored cancer screening programs are increasing biopsy procedure volumes.
• Barriers include limited availability of advanced devices in rural regions and high device costs.
Leading Players in the Asia-Pacific market include BD (Becton, Dickinson and Company), Boston Scientific, Hologic, Medtronic, Cook Medical, Argon Medical Devices, and Fujifilm Holdings.
Segmentation Analysis
By Product
• Needle-Based Biopsy Instruments
• Core Biopsy Devices
• Vacuum-Assisted Biopsy Devices
• Fine Needle Aspiration Devices
• Forceps & Other Instruments
By Platform
• Imaging-Guided Biopsy Systems (Ultrasound, CT, MRI-guided)
• Robotic Biopsy Systems
• Manual Biopsy Devices
By Technology
• Stereotactic-Guided Biopsy
• Ultrasound-Guided Biopsy
• MRI-Guided Biopsy
• Optical Biopsy Technologies
By End-Use
• Hospitals
• Specialty Diagnostic Centers
• Academic & Research Institutes
• Ambulatory Surgical Centers
By Application
• Breast Biopsy
• Lung Biopsy
• Liver Biopsy
• Prostate Biopsy
• Kidney Biopsy
• Others (skin, bone, etc.)
Segmentation Summary
Breast biopsy remains the leading application, driven by rising breast cancer cases in urban Asia-Pacific populations. Lung and liver biopsies are also increasing due to the prevalence of smoking-related diseases and hepatitis-related conditions. Among devices, vacuum-assisted biopsy systems are expected to grow fastest, providing higher accuracy with minimal invasiveness. Imaging-guided platforms dominate, with robotic systems showing significant potential as healthcare systems adopt advanced technologies.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72316/asia-pacific-biopsy-devices-market
Regional Analysis
China
• Largest market in Asia-Pacific with strong government support for cancer screening.
• Rapid adoption of advanced biopsy technologies in urban hospitals.
• High incidence of lung and liver cancer drives biopsy demand.
India
• Growing awareness and government cancer control programs expanding diagnostic services.
• Cost-sensitive market but rising private hospital investments boost adoption of modern biopsy devices.
Japan
• Mature healthcare market with high penetration of advanced technologies.
• Strong demand for minimally invasive and robotic biopsy systems.
South Korea
• Rapid adoption of digital pathology and imaging-guided biopsy techniques.
• Government funding supports early cancer screening initiatives.
Australia
• Advanced healthcare system with high cancer screening participation.
• Increasing demand for breast and skin biopsies.
Southeast Asia
• Growing healthcare investments in countries such as Thailand, Malaysia, and Indonesia.
• Expanding private hospital networks offering advanced biopsy services.
Regional Summary
China and India dominate in terms of patient volume, while Japan, South Korea, and Australia lead in terms of technology adoption. Southeast Asia offers strong growth potential as healthcare infrastructure and diagnostic awareness improve.
Market Dynamics
Growth Drivers
1. Rising cancer incidence - The increasing prevalence of breast, lung, liver, and prostate cancers drives biopsy volumes.
2. Shift toward minimally invasive techniques - Patients and physicians favor less invasive methods that reduce risks and recovery times.
3. Government screening programs - National initiatives for breast, cervical, and colorectal cancer screening are boosting biopsy demand.
4. Technological innovation - Imaging-guided and robotic-assisted biopsies enhance diagnostic accuracy.
Challenges
• High cost of advanced biopsy systems limits accessibility in rural areas.
• Shortage of skilled pathologists and trained operators.
• Reimbursement gaps in certain Asia-Pacific countries.
Latest Trends
• Increasing use of AI-powered imaging systems in biopsy guidance.
• Expansion of robotic-assisted biopsy platforms in Japan and South Korea.
• Growing focus on liquid biopsy as a complementary technology, though tissue biopsy remains the gold standard.
• Rising number of public-private partnerships to expand access to advanced biopsy devices in emerging markets.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72316
Competitor Analysis
Major Players in Asia-Pacific
• BD (Becton, Dickinson and Company)
• Boston Scientific Corporation
• Hologic Inc.
• Medtronic plc
• Cook Medical
• Argon Medical Devices
• Fujifilm Holdings Corporation
• Olympus Corporation
• Devicor Medical Products (part of Leica Biosystems)
• Cardinal Health
Competitive Landscape Summary
The market is highly competitive, with multinational giants such as BD, Boston Scientific, and Hologic leading through strong product portfolios and distribution networks. Regional players, including Fujifilm and Olympus, play a vital role in technology innovation tailored to Asia-Pacific needs. Partnerships, acquisitions, and product launches are key strategies, with a focus on expanding into emerging high-growth markets such as India and Southeast Asia.
Conclusion
The Asia-Pacific Biopsy Devices Market is projected to grow from USD 2.3 billion in 2024 to USD 5.4 billion by 2034, at a CAGR of 8.9%. Rising cancer prevalence, government-backed screening programs, and advances in minimally invasive technologies are fueling growth across the region.
Key Takeaways
• Breast, lung, and liver biopsies will remain the leading applications.
• Vacuum-assisted and imaging-guided devices are the fastest-growing technology segments.
• China and India dominate by volume, while Japan, South Korea, and Australia lead in advanced device adoption.
• Competitive dynamics revolve around affordability, innovation, and regional expansion.
This report is also available in the following languages : Japanese (アジア太平洋地域の生検装置市場), Korean (아시아 태평양 생체검사 장비 시장), Chinese (亚太活检设备市场), French (Marché des dispositifs de biopsie en Asie-Pacifique), German (Markt für Biopsiegeräte im asiatisch-pazifischen Raum), and Italian (Mercato dei dispositivi per biopsia nell'area Asia-Pacifico), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72316
Our More Reports:
Persistent Epithelial Defect Market
https://exactitudeconsultancy.com/reports/72290/persistent-epithelial-defect-market
Neuropathic Ocular Pain (NOP)â€"Market
https://exactitudeconsultancy.com/reports/72288/neuropathic-ocular-pain-nop-market
Granulomatosis With Polyangiitis â€" Market
https://exactitudeconsultancy.com/reports/72286/granulomatosis-with-polyangiitis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Biopsy Devices Market Projected to Grow at 8.9% CAGR, Reaching USD 5.4 Billion by 2034 here
News-ID: 4195882 • Views: …
More Releases from Exactitude Consultancy
Myopia Treatment Devices Market to Reach USD 4.6 Billion by 2034
Myopia, commonly known as nearsightedness, is a refractive error in which distant objects appear blurry while near objects are clear. It is caused by an elongated eyeball or excessive curvature of the cornea, resulting in the light focusing in front of the retina. The condition is becoming increasingly prevalent worldwide, especially in younger populations, as a result of extended screen time, lack of outdoor activities, and genetic predisposition.
Download Full PDF…
BRIC Biopsy Devices Market Forecast to Grow at 9.1% CAGR, Reaching USD 7.4 Billi …
Introduction
Biopsy devices are essential tools in modern healthcare, particularly in cancer detection, staging, and treatment planning. As the global cancer burden rises, early detection has become more critical than ever. In the BRIC nations - Brazil, Russia, India, and China - the demand for biopsy devices is accelerating due to demographic transitions, increasing awareness, and expanding healthcare access.
These four countries collectively represent more than 40% of the global population, making…
Ophthalmic Ultrasound Devices Market to Reach USD 3.1 Billion by 2034
Ophthalmic ultrasound devices are crucial tools in diagnostic imaging for eye diseases such as retinal detachment, cataracts, glaucoma, and macular degeneration. These devices provide non-invasive, real-time imaging, making them indispensable in ophthalmic practices. The technology helps in visualizing internal eye structures, measuring intraocular pressure (IOP), and detecting abnormalities that affect vision.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72303
With the global increase in eye-related disorders, such as age-related macular…
Cloud Computing in Healthcare Market Set to Grow at 11.2% CAGR, Reaching USD 115 …
Introduction
Healthcare systems worldwide are undergoing a digital revolution, with cloud computing at the heart of this transformation. The shift to cloud-based platforms allows hospitals, clinics, and research organizations to store, manage, and analyze large volumes of data securely and cost-effectively. From electronic health records (EHRs) and telemedicine to artificial intelligence (AI)-driven diagnostics and personalized treatments, cloud computing is enabling new levels of connectivity, scalability, and efficiency.
The importance of cloud computing…
More Releases for Biopsy
Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430
This latest report researches the industry structure, sales, revenue,…
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .
Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East…
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares
Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and…
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,…
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from…
